INTRODUCTION: There are few studies that investigate the usefulness of the preoperative intragastric balloon (IGB). This study will evaluate if pre-surgical weight loss with IGB reduces morbidity and mortality after surgery. METHOD: Prospective randomised study of patients with morbid obesity treated with gastric bypass or vertical gastrectomy, with two arms: the balloon arm (B-arm), where an IGB was inserted within the 6 months before surgery, and the control arm (C-arm). RESULTS: The study included 66 patients: 65.6% women, 69.6% with bypass. Age: 43 years (SD 10.2) B-arm and 42.6 years (SD 9.2) in the C-arm. We found 34.4% therapeutic failures in IGB. The mean body weight loss, %EWL and BMI reduction before surgery was 16.2 kg (SD 9.84) B-arm versus 4.7 (SD 8.70) in the C-arm, 23.6% versus 4.7% (p < 0.001) and 6.04 versus 1 (p < 0.001), respectively. The hospital stay was 7 days (p25-75: 5-8) B-arm and 7 days (p25-75: 5-9) in the C-arm (p = 0.937). Post-surgical morbidity with IGB was 25% versus 29.5% in the C-arm, p = 0.689. The number needed to treat (NNT) to prevent of post-surgical morbidity was 23 patients. The B-arm presented 54.5% moderate-severe post-surgical adverse events (12.5%) versus 82.6% in the C-arm (23.5%), p = 0.111. The cost of placing a balloon was more than 4000 Euros each. CONCLUSIONS: The preoperative balloon does not achieve a reduction in the post-surgical morbidity, nor does it reduce the hospital stay or rate of re-operations. The balloon achieves a higher weight loss result when compared to a diet programme, its added cost must also be given due consideration. TRAIL REGISTRY: This study has been registered on ClinicalTrials.gov with the Identifier: NCT01998243 (November 28, 2013).
RCT Entities:
INTRODUCTION: There are few studies that investigate the usefulness of the preoperative intragastric balloon (IGB). This study will evaluate if pre-surgical weight loss with IGB reduces morbidity and mortality after surgery. METHOD: Prospective randomised study of patients with morbid obesity treated with gastric bypass or vertical gastrectomy, with two arms: the balloon arm (B-arm), where an IGB was inserted within the 6 months before surgery, and the control arm (C-arm). RESULTS: The study included 66 patients: 65.6% women, 69.6% with bypass. Age: 43 years (SD 10.2) B-arm and 42.6 years (SD 9.2) in the C-arm. We found 34.4% therapeutic failures in IGB. The mean body weight loss, %EWL and BMI reduction before surgery was 16.2 kg (SD 9.84) B-arm versus 4.7 (SD 8.70) in the C-arm, 23.6% versus 4.7% (p < 0.001) and 6.04 versus 1 (p < 0.001), respectively. The hospital stay was 7 days (p25-75: 5-8) B-arm and 7 days (p25-75: 5-9) in the C-arm (p = 0.937). Post-surgical morbidity with IGB was 25% versus 29.5% in the C-arm, p = 0.689. The number needed to treat (NNT) to prevent of post-surgical morbidity was 23 patients. The B-arm presented 54.5% moderate-severe post-surgical adverse events (12.5%) versus 82.6% in the C-arm (23.5%), p = 0.111. The cost of placing a balloon was more than 4000 Euros each. CONCLUSIONS: The preoperative balloon does not achieve a reduction in the post-surgical morbidity, nor does it reduce the hospital stay or rate of re-operations. The balloon achieves a higher weight loss result when compared to a diet programme, its added cost must also be given due consideration. TRAIL REGISTRY: This study has been registered on ClinicalTrials.gov with the Identifier: NCT01998243 (November 28, 2013).
Authors: C H Wahlen; B Bastens; J Herve; C Malmendier; B Dallemagne; C Jehaes; S Markiewicz; B Monami; J Weerts Journal: Obes Surg Date: 2001-08 Impact factor: 4.129
Authors: R-A Mazure; I Breton; E Cancer; C Mellado; V Abilés; J Avilés; M A Escarti; R Ginés; V Alvarez; N Paez; C Velasco; L Pavón; M Miras; M Martínez Olmo; J M Culebras Journal: Nutr Hosp Date: 2009 Mar-Apr Impact factor: 1.057
Authors: J L Gutiérrez-Fisac; P Guallar-Castillón; L M León-Muñoz; A Graciani; J R Banegas; F Rodríguez-Artalejo Journal: Obes Rev Date: 2011-12-12 Impact factor: 9.213
Authors: Carlos Zerrweck; Vincent Maunoury; Robert Caiazzo; Julien Branche; Guélareh Dezfoulian; Philippe Bulois; Helene Verkindt; Marie Pigeyre; Laurent Arnalsteen; François Pattou Journal: Obes Surg Date: 2012-05 Impact factor: 4.129
Authors: Barham K Abu-Dayyeh; Ray Sarmiento; Elizabeth Rajan; Enrique Vázquez-Sequeiros; Christopher J Gostout Journal: Rev Esp Enferm Dig Date: 2014-08 Impact factor: 2.086
Authors: M Fernandes; A N Atallah; B G O Soares; S Humberto; S Guimarães; D Matos; L Monteiro; B Richter Journal: Cochrane Database Syst Rev Date: 2007-01-24